Dimerix

Dimerix Days Payable Outstanding

The Days Payable Outstanding (DPO) of Dimerix (DXB.AX) as of Oct 11, 2026 is 6,030.53. In the previous year, Days Payable Outstanding (DPO) was 33,477.60 — a change of -81.99% (lower).

Days Payable Outstanding

6,030.53

YoY

-81.99%

Last updated:

Days Payable Outstanding (DPO) of Dimerix is 2026 6,030.53 . Days Payable Outstanding (DPO) of Dimerix was 2025 33,477.60 . It decreases by -81.99% lower compared to the previous year.

The Dimerix Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2017
20,026.73 AUD
Jan 1, 2018
15,303.74 AUD
Jan 1, 2019
32,529.33 AUD
Jan 1, 2020
30,997.51 AUD
Jan 1, 2021
20,626.31 AUD
Jan 1, 2022
8,021.64 AUD
Jan 1, 2023
33,477.60 AUD
Jan 1, 2026
6,030.53 AUD
The Dimerix Days Payable Outstanding history
YEARDays Payable OutstandingYoY
6,030.53-81.99%
33,477.60+317.34%
8,021.64-61.11%
20,626.31-33.46%
30,997.51-4.71%
32,529.33+112.56%
15,303.74-23.58%
20,026.73-21.41%
25,481.74-47.71%
48,729.65+11,166.74%
432.51—
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Days Payable Outstanding (DPO) of Dimerix is 6,030.53 in 2026.

Days Payable Outstanding (DPO) of Dimerix changed from 33,477.60 to 6,030.53, representing a -81.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Dimerix since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Dimerix with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

Profitability — Dimerix

All Key Metrics — Dimerix